Gideon Davies | |
---|---|
Born | Gideon John Davies 6 July 1964 [1] |
Nationality | British |
Alma mater | University of Bristol (BSc, PhD, DSc) |
Children | Two daughters [1] |
Awards |
|
Scientific career | |
Fields | |
Institutions | |
Thesis | Phosphoglycerate kinase from Bacillus stearothermophilus (1990) |
Doctoral advisor |
|
Doctoral students | Tracey Gloster [6] |
Website | www |
Gideon John Davies (born 6 July 1964) FRS FRSC FMedSci is a professor of chemistry in the Structural Biology Laboratory (YSBL) at the University of York, UK. [3] [7] [8] Davies is best known for his ground-breaking studies into carbohydrate-active enzymes, notably analysing the conformational and mechanistic basis for catalysis and applying this for societal benefit. In 2016 Davies was appointed the Royal Society Ken Murray Research Professor at the University of York. Gideon Davies has recently been elected to the Council of the Royal Society.
Davies was educated at the University of Bristol where he was awarded a Bachelor of Science degree in Biochemistry and a PhD in 1990 for research on the enzyme phosphoglycerate kinase isolated from the bacterium Bacillus stearothermophilus , and supervised by Herman Watson and Len Hall. [5] [9] He was awarded a Doctor of Science (DSc) degree from the University of Bristol in 2007. [2]
Following his PhD, Davies did postdoctoral research at the European Molecular Biology Laboratory (EMBL) outstation in Hamburg working with Keith S. Wilson on the use of synchrotron radiation in protein crystallography and also at the French National Centre for Scientific Research (CNRS) in Grenoble. [10] in 1990, Davies moved to York to work with Dale Wigley and Guy Dodson on DNA gyrase, starting his own group within YSBL in 1996 upon receiving a Royal Society University Research Fellowship. [11] He was appointed Professor at the University of York in 2001 [10] and awarded a Royal Society Ken Murray Research Professorship [12] in 2016. He has collaborated with Alywn Jones, Bernard Henrissat, [13] [14] Steve Withers and David Vocadlo. [4] Among those who undertook doctoral research with him are Tracey Gloster. [6]
Davies research investigates the biological chemistry of carbohydrates, from their structure [15] [16] [17] to their roles in enzymology, [18] [19] glycobiology, [20] [21] [22] [23] use as biofuels [24] [25] [26] and implications for gut microbiota. [27] [28] His research has been funded by the Biotechnology and Biological Sciences Research Council (BBSRC), [29] European Research Council (ERC) and Alzheimer's Research UK. [10]
Davies has over 400 publications in peer-reviewed journals. [3] [7] [8]
Davies has won a number of awards for his work. These include The Davy Medal and Gabor Medal of the Royal Society, the John and Rita Cornforth Award (with Paul Walton [30] ), the Haworth Memorial, Khorana, Peptide and Protein, Corday-Morgan and Carbohydrate Chemistry medals of the Royal Society of Chemistry, the iChemE Global Energy Award of the Institution of Chemical Engineers (with Paul Walton and Bernard Henrissat), The Whistler Prize of the International Carbohydrate Organization, [31] and the GlaxoSmithKline Award [32] of the Biochemical Society. In 2019 he was one of the members of the York Structural Biology Laboratory at the University of York that received the Queen's Anniversary Prize.
Davies was elected a member of the European Molecular Biology Organization (EMBO) in 2010 [10] and is a Fellow of the Royal Society of Chemistry (FRSC)
In 2010, Davies was elected a Fellow of the Royal Society (FRS). His nomination reads:
Professor Gideon Davies' research is focused on "structural enzymology". In this he addresses the enzymes, and their accessory domains, that are involved in the synthesis, modification and breakdown of carbohydrates. His chemical and structural insight into protein-carbohydrate interactions and his brilliant exploitation of advanced crystallographic methods provide the basis for understanding how the chemical and structural factors in the stereochemical pathway of the enzyme:substrate complex govern specificity and catalysis. His research is having an immense impact on carbohydrate chemistry and biology and biological catalysis generally. [33]
Davies was elected a Fellow of the Academy of Medical Sciences (FMedSci) in 2014, his nomination reads
Gideon Davies, who is Professor of Biological Chemistry at University of York, has made world-leading contributions to Biochemistry. He has made fundamental additions to our understanding of enzyme mechanism and carbohydrate biochemistry. As a direct result of his work into the conformation of sugars during turnover, he described the rational design of highly potent inhibitors of O-linked glucosamine modifying enzymes. These compounds are showing potential as treatments for Alzheimer's disease. Recently he has turned to study the human microbiota, which are now recognised to be an essential component of human health, and their carbohydrate metabolism is implicated in several disease states. [34]
He was awarded the John and Rita Cornforth Award of Royal Society of Chemistry in 2020 [35] and the Queen's Anniversary Prize (to YSBL) in 2019 [36] He was a Haworth Memorial Lectureship of Royal Society of Chemistry in 2018 [37] and a Global Energy Award of Institution of Chemical Engineers winner in 2016. [38]
Davies married Valérie Marie-Andrée Ducros [39] in 1999 (div. 2021) and has two daughters. [1]
Lysozyme is an antimicrobial enzyme produced by animals that forms part of the innate immune system. It is a glycoside hydrolase that catalyzes the following process:
Sir Alan Roy Fersht is a British chemist at the MRC Laboratory of Molecular Biology, Cambridge, and an Emeritus Professor in the Department of Chemistry at the University of Cambridge. He was Master of Gonville and Caius College, Cambridge from 2012 to 2018. He works on protein folding, and is sometimes described as a founder of protein engineering.
Sir Gregory Paul Winter is a Nobel Prize-winning English molecular biologist best known for his work on the therapeutic use of monoclonal antibodies. His research career has been based almost entirely at the MRC Laboratory of Molecular Biology and the MRC Centre for Protein Engineering, in Cambridge, England.
Christopher Abell was a British biological chemist who was a professor of biological chemistry at the Yusuf Hamied Department of Chemistry and Todd-Hamied Fellow of Christ's College, Cambridge. On his 2016 election to the Royal Society, Abell's research was described as having "changed the face of drug discovery."
In biochemistry, glycoside hydrolases are a class of enzymes which catalyze the hydrolysis of glycosidic bonds in complex sugars. They are extremely common enzymes, with roles in nature including degradation of biomass such as cellulose (cellulase), hemicellulose, and starch (amylase), in anti-bacterial defense strategies, in pathogenesis mechanisms and in normal cellular function. Together with glycosyltransferases, glycosidases form the major catalytic machinery for the synthesis and breakage of glycosidic bonds.
Dame Janet Maureen Thornton, is a senior scientist and director emeritus at the European Bioinformatics Institute (EBI), part of the European Molecular Biology Laboratory (EMBL). She is one of the world's leading researchers in structural bioinformatics, using computational methods to understand protein structure and function. She served as director of the EBI from October 2001 to June 2015, and played a key role in ELIXIR.
Dame Carol Vivien Robinson, is a British chemist and former president of the Royal Society of Chemistry (2018–2020). She was a Royal Society Research Professor and is the Dr Lee's Professor of Physical and Theoretical Chemistry, and a professorial fellow at Exeter College, University of Oxford. She is the first director of the Kavli Institution for Nanoscience Discovery, University of Oxford, and she was previously professor of mass spectrometry at the chemistry department of the University of Cambridge.
George Guy Dodson FRS FMedSci, was a British biochemist who specialised in protein crystallography at the University of York.
In molecular biology, glycoside hydrolase family 4 is a family of glycoside hydrolases EC 3.2.1., which are a widespread group of enzymes that hydrolyse the glycosidic bond between two or more carbohydrates, or between a carbohydrate and a non-carbohydrate moiety. A classification system for glycoside hydrolases, based on sequence similarity, has led to the definition of >100 different families. This classification is available on the CAZy web site, and also discussed at CAZypedia, an online encyclopedia of carbohydrate active enzymes.
In molecular biology, glycoside hydrolase family 5 is a family of glycoside hydrolases EC 3.2.1., which are a widespread group of enzymes that hydrolyse the glycosidic bond between two or more carbohydrates, or between a carbohydrate and a non-carbohydrate moiety. A classification system for glycoside hydrolases, based on sequence similarity, has led to the definition of >100 different families. This classification is available on the CAZy web site, and also discussed at CAZypedia, an online encyclopedia of carbohydrate active enzymes.
Sir Shankar Balasubramanian is an Indian-born British chemist and Herchel Smith Professor of Medicinal Chemistry in the Department of Chemistry at the University of Cambridge, Senior Group Leader at the Cancer Research UK Cambridge Institute and Fellow of Trinity College, Cambridge. He is recognised for his contributions in the field of nucleic acids. He is scientific founder of Solexa and biomodal.
James Henderson Naismith is Professor of Structural Biology at the University of Oxford, former Director of the Research Complex at Harwell and Director of the Rosalind Franklin Institute. He previously served as Bishop Wardlaw Professor of Chemical Biology at the University of St Andrews. He was a member of Council of the Royal Society (2021-2022). He is currently the Vice-Chair of Council of the European X-ray Free Electron Laser and Vice-President (non-clinical) of The Academy of Medical Sciences. It has been announced that he will be the Head of the MPLS division at Oxford in the autumn of 2023.
Benjamin Guy Davis is Professor of Chemical biology in the Department of Pharmacology and a member of the Faculty in the Department of Chemistry at the University of Oxford and a Fellow of Pembroke College, Oxford. He holds the role of Science Director for Next Generation Chemistry (2019-2024) and Deputy Director (2020-) at the Rosalind Franklin Institute.
David Chaim Rubinsztein FRS FMedSci is the Deputy Director of the Cambridge Institute of Medical Research (CIMR), Professor of Molecular Neurogenetics at the University of Cambridge and a UK Dementia Research Institute Professor.
Harry J. Gilbert is Professor of Agricultural Biochemistry and Nutrition in the Institute For Cell and Molecular Biosciences at Newcastle University.
Nigel Shaun Scrutton is a British biochemist and biotechnology innovator known for his work on enzyme catalysis, biophysics and synthetic biology. He is Director of the UK Future Biomanufacturing Research Hub, Director of the Fine and Speciality Chemicals Synthetic Biology Research Centre (SYNBIOCHEM), and Co-founder, Director and Chief Scientific Officer of the 'fuels-from-biology' company C3 Biotechnologies Ltd. He is Professor of Enzymology and Biophysical Chemistry in the Department of Chemistry at the University of Manchester. He is former Director of the Manchester Institute of Biotechnology (MIB).
Judy Hirst is a British scientist specialising in mitochondrial biology. She is Director of the MRC Mitochondrial Biology Unit at the University of Cambridge.
Sabine Flitsch is a German organic chemist and chemical biologist who holds a personal chair in Chemical Biology at the University of Manchester School of Chemistry, where she runs an active research glycobiology research group based in the Manchester Interdisciplinary Biocentre.
Nicholas John Turner, is a British chemist and a Professor in the Department of Chemistry at The University of Manchester. His research in general is based on biochemistry and organic chemistry, specifically on biotechnology, cell biology, biocatalysis and organic synthesis.
Tracey Maureen Gloster is a chemist at the University of St Andrews UK. Her research interests are in structural biology, chemical biology, glycobiology and carbohydrate processing enzymes.